These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 14625684)
21. The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT. Li X; McDonnell DP Mol Cell Biol; 2002 Jun; 22(11):3663-73. PubMed ID: 11997503 [TBL] [Abstract][Full Text] [Related]
22. B-Myb, a repressed trans-activating protein. Ansieau S; Kowenz-Leutz E; Dechend R; Leutz A J Mol Med (Berl); 1997; 75(11-12):815-9. PubMed ID: 9428611 [TBL] [Abstract][Full Text] [Related]
23. Proto-oncogenic properties of the DP family of proteins. Jooss K; Lam EW; Bybee A; Girling R; Müller R; La Thangue NB Oncogene; 1995 Apr; 10(8):1529-36. PubMed ID: 7731707 [TBL] [Abstract][Full Text] [Related]
24. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation. Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185 [TBL] [Abstract][Full Text] [Related]
25. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation. Lane S; Farlie P; Watson R Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859 [TBL] [Abstract][Full Text] [Related]
26. The cooperation of B-Myb with the coactivator p300 is orchestrated by cyclins A and D1. Schubert S; Horstmann S; Bartusel T; Klempnauer KH Oncogene; 2004 Feb; 23(7):1392-404. PubMed ID: 14973551 [TBL] [Abstract][Full Text] [Related]
27. Cell cycle regulation of E2F site occupation in vivo. Zwicker J; Liu N; Engeland K; Lucibello FC; Müller R Science; 1996 Mar; 271(5255):1595-7. PubMed ID: 8599118 [TBL] [Abstract][Full Text] [Related]
28. Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells. Tavner F; Frampton J; Watson RJ Oncogene; 2007 Apr; 26(19):2727-35. PubMed ID: 17072340 [TBL] [Abstract][Full Text] [Related]
29. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites. Bartusel T; Schubert S; Klempnauer KH Gene; 2005 May; 351():171-80. PubMed ID: 15922873 [TBL] [Abstract][Full Text] [Related]
30. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Sala A; Nicolaides NC; Engelhard A; Bellon T; Lawe DC; Arnold A; Graña X; Giordano A; Calabretta B Cancer Res; 1994 Mar; 54(6):1402-6. PubMed ID: 8137237 [TBL] [Abstract][Full Text] [Related]
31. E2Fs link the control of G1/S and G2/M transcription. Zhu W; Giangrande PH; Nevins JR EMBO J; 2004 Nov; 23(23):4615-26. PubMed ID: 15510213 [TBL] [Abstract][Full Text] [Related]
32. Regulation of B-Myb activity by cyclin D1. Horstmann S; Ferrari S; Klempnauer KH Oncogene; 2000 Jan; 19(2):298-306. PubMed ID: 10645009 [TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation of the murine surfactant protein-A gene by B-Myb. Bruno MD; Whitsett JA; Ross GF; Korfhagen TR J Biol Chem; 1999 Sep; 274(39):27523-8. PubMed ID: 10488087 [TBL] [Abstract][Full Text] [Related]
34. A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells. Knight AS; Notaridou M; Watson RJ Oncogene; 2009 Apr; 28(15):1737-47. PubMed ID: 19252525 [TBL] [Abstract][Full Text] [Related]
35. Regulation of the cell cycle by B-Myb. Bessa M; Joaquin M; Tavner F; Saville MK; Watson RJ Blood Cells Mol Dis; 2001; 27(2):416-21. PubMed ID: 11259164 [TBL] [Abstract][Full Text] [Related]
36. Functional conservation of the cell cycle-regulating transcription factor DRTF1/E2F and its pathway of control in Drosophila melanogaster. Hao XF; Alphey L; Bandara LR; Lam EW; Glover D; La Thangue NB J Cell Sci; 1995 Sep; 108 ( Pt 9)():2945-54. PubMed ID: 8537434 [TBL] [Abstract][Full Text] [Related]
37. GABP cooperates with c-Myb and C/EBP to activate the neutrophil elastase promoter. Nuchprayoon I; Simkevich CP; Luo M; Friedman AD; Rosmarin AG Blood; 1997 Jun; 89(12):4546-54. PubMed ID: 9192779 [TBL] [Abstract][Full Text] [Related]
38. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576 [TBL] [Abstract][Full Text] [Related]
39. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. Sala A; Casella I; Bellon T; Calabretta B; Watson RJ; Peschle C J Biol Chem; 1996 Apr; 271(16):9363-7. PubMed ID: 8621601 [TBL] [Abstract][Full Text] [Related]
40. B-myb rescues ras-induced premature senescence, which requires its transactivation domain. Masselink H; Vastenhouw N; Bernards R Cancer Lett; 2001 Sep; 171(1):87-101. PubMed ID: 11485831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]